不妊治療薬の世界市場レポート 2024

不妊治療薬の市場規模は、今後数年間で着実に成長すると予想されます。 2028年には3.3%の年間複合成長率（CAGR）で31億1,000万米ドルに成長すると予想されます。予測期間中に予測される成長は、人口の高齢化、生殖能力に影響を与えるライフスタイル関連要因、生殖補助医療（ART）の継続的な進歩と利用、不妊治療における個別化医療の出現などの要因によって推進されると予想されます。この期間に予想される主要な動向には、ARTのさらなる進歩、排卵誘発剤の開発、不妊治療におけるホルモン療法の利用が含まれます。

不妊治療薬に対する需要の高まりは、1年間継続的に妊娠を試みても妊娠できないことと定義される不妊率の世界の急増にその原動力となっています。この市場の成長は、男性と女性の両方の不妊症に寄与するライフスタイルおよび環境要因に加え、生理学的およびホルモンの問題の有病率の増加によって推進されています。世界保健機関が2023年 4月に発表した報告書では、成人の6人に1人、または世界の成人人口の約17.5%に相当する世界中の数百万人が不妊症に悩まされ、家族や地域社会に大きな影響を与えると推定されています。その結果、世界的に不妊症の症例が急増しているため、不妊治療薬の必要性が高まり、不妊治療薬市場の成長が促進されています。

不妊治療薬市場の予想される成長は、男性と女性の不妊症に大きく関連する肥満の有病率の増加によってさらに促進されます。この傾向は、専門的な治療法、意識の向上、支援的な政府政策、そして肥満に関連する生殖能力の課題に対処することを目的とした継続的な調査活動の必要性から生じています。 2023年 3月に世界心臓連盟が発表したデータによると、成人と子供を含め、世界中で23億人という驚くべき人々が肥満または過体重状態に陥っていることが明らかになりました。予測では増加傾向が示されており、2025年までに27億人に増加すると予測されています。このように、肥満の急増は不妊治療薬市場の成長を推進する原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の不妊治療薬市場、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 不妊治療薬処方
• 市販不妊治療薬
• 世界の不妊治療薬市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 静脈内
• 皮下
• 筋肉内
• 世界の不妊治療薬市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局

第7章 地域および国の分析

• 世界の不妊治療薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の不妊治療薬市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 不妊治療薬市場の競合情勢
• 不妊治療薬市場の企業プロファイル
  • Merck &Co.
  • Ferring Pharmaceuticals Inc.
  • Bayer AG
  • Berlex Laboratories Inc.
  • Janssen Pharmaceutical Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Fertility drugs encompass medications designed to stimulate the body's hormone release, regulating and prompting ovulation-the release of eggs from the ovaries.

These drugs fall into two main categories include prescription fertility drugs and over-the-counter variants. They are administered through various methods including oral ingestion, intravenous injection, subcutaneous injection (into the fatty tissue just below the skin), and intramuscular injection, catering to both male and female patients. Distribution channels for these drugs span hospital pharmacies, retail outlets, and online pharmacies, ensuring accessibility across different avenues for patients seeking fertility treatment.

The fertility drugs market research report is one of a series of new reports from The Business Research Company that provides fertility drugs market statistics, including fertility drugs industry global market size, regional shares, competitors with a fertility drugs market share, detailed fertility drugs market segments, market trends and opportunities, and any further data you may need to thrive in the fertility drugs industry. This fertility drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility drugs market size has grown steadily in recent years. It will grow from $2.63 billion in 2023 to $2.73 billion in 2024 at a compound annual growth rate (CAGR) of 3.7%. The expansion observed in the historical period can be attributed to several factors including the rise in infertility rates, advancements in reproductive medicine, the widespread adoption of assisted reproductive technologies (ART), and the trend of delayed childbearing among individuals and couples.

The fertility drugs market size is expected to see steadily grown in the next few years. It will grow to $3.11 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. The projected growth in the forecast period is expected to be driven by factors such as the aging population, lifestyle-related factors influencing fertility, the continued advancement and utilization of assisted reproductive technologies (ART), and the emergence of personalized medicine in fertility treatments. Key trends anticipated for this period encompass further advancements in ART, the development of ovulation-inducing medications, and the utilization of hormone therapy within fertility treatments.

The escalating demand for fertility drugs finds its impetus in the surging global rates of infertility, defined as the inability to conceive after a year of continuous attempts. This market growth is propelled by the increased prevalence of physiological and hormonal issues, along with lifestyle and environmental factors contributing to infertility in both men and women. A report from the World Health Organization in April 2023 estimates that millions worldwide, accounting for 1 in 6 adults or roughly 17.5% of the global adult population, will grapple with infertility, substantially impacting families and communities. Consequently, the burgeoning cases of infertility globally are driving the increased need for fertility drugs, thereby augmenting growth in the fertility drug market.

Anticipated growth in the fertility drugs market is further propelled by the mounting prevalence of obesity, a condition significantly associated with infertility in men and women. This trend stems from the imperative for specialized treatments, augmented awareness, supportive governmental policies, and ongoing research endeavors aimed at addressing fertility challenges linked to obesity. Data from the World Heart Federation in March 2023 reveals a staggering 2.3 billion individuals, both adults and children, affected by obesity or overweight conditions globally. Projections indicate an upward trend, with estimates foreseeing a rise to 2.7 billion by 2025. Thus, the burgeoning prevalence of obesity serves as a driving force propelling growth within the fertility drugs market.

Companies within the fertility drugs sector are strategically focused on introducing user-friendly solutions for advanced infertility treatments, exemplified by self-administration fertility solutions. These innovations aim to alleviate discomfort and simplify the process of daily injections, particularly for women. An instance is the August 2021 launch of the Pergoveris Pen by Merck Specialties in India, designed for women with severe FSH and LH deficiencies. This self-administration system, comprising freeze-dried powder and solvent, minimizes reconstitution errors and ensures precise delivery, enhancing accessibility for patients managing infertility treatments.

Major players in the fertility drugs market are launching comprehensive campaigns centered around fertility care, aiming to secure competitive advantages. These campaigns, designed to raise awareness and educate the public on fertility-related issues, treatments, and reproductive health, play a crucial role in safeguarding access to fertility care. Pinnacle Fertility's August 2022 initiative, the Save IVF campaign in the US, is a prime example. Focused on potential legislation affecting family-building treatments like IVF in the absence of federal protection, this campaign advocates for preserving fertility care access. By mobilizing communities and encouraging individuals to support the cause through the #SaveIVF Pledge, Pinnacle Fertility seeks to protect fertility treatments' accessibility and combat legislative threats.

In March 2023, Sumitovant Biopharma Ltd., a US-based biopharmaceutical company, finalized the acquisition of Myovant Sciences Ltd. for an undisclosed sum. This strategic acquisition amplifies Sumitovant's collaborative capabilities, resources, and expertise, enabling them to effectively tackle unmet needs in women's health and prostate cancer. The combined entity aims to advance their joint pipeline's development, extending the reach of their distinct therapies to benefit diverse patient communities. Myovant Sciences Ltd., a US-based biotechnology firm, specializes in developing and commercializing novel treatments for women's diseases and endocrine disorders. Their focus areas include addressing conditions like heavy menstrual bleeding associated with uterine fibroids and female infertility. This acquisition marks a pivotal step for both companies in bolstering their offerings and impact within these critical medical domains.

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical co. Ltd., AstraZeneca PLC, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Alnylam Pharmaceuticals Inc., Argos Distributors Limited, Sarepta Therapeutics Inc., Moderna Inc., BioNTech SE, Biogen Inc.

North America was the largest region in the fertility drugs market in 2023. The Middle East is expected to be the fastest-growing region in the drugs for infertility market during the forecast period. The regions covered in the fertility drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The fertility drugs market consists of sales of clomiphene citrate, gonadotropins, and metformin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fertility Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fertility drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fertility drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fertility drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs
• 2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Sub-Segments

• By Gender: Male; Female
• Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals Inc.; Bayer AG; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fertility Drugs Market Characteristics

3. Fertility Drugs Market Trends And Strategies

4. Fertility Drugs Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Fertility Drugs Market Size and Growth

• 5.1. Global Fertility Drugs Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Fertility Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Fertility Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fertility Drugs Market Segmentation

• 6.1. Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Prescription Fertility Drugs
• Over-The-Counter Fertility Drugs
• 6.2. Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• 6.3. Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

7. Fertility Drugs Market Regional And Country Analysis

• 7.1. Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fertility Drugs Market

• 8.1. Asia-Pacific Fertility Drugs Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fertility Drugs Market

• 9.1. China Fertility Drugs Market Overview
• 9.2. China Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fertility Drugs Market

• 10.1. India Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fertility Drugs Market

• 11.1. Japan Fertility Drugs Market Overview
• 11.2. Japan Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fertility Drugs Market

• 12.1. Australia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fertility Drugs Market

• 13.1. Indonesia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fertility Drugs Market

• 14.1. South Korea Fertility Drugs Market Overview
• 14.2. South Korea Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fertility Drugs Market

• 15.1. Western Europe Fertility Drugs Market Overview
• 15.2. Western Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fertility Drugs Market

• 16.1. UK Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fertility Drugs Market

• 17.1. Germany Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fertility Drugs Market

• 18.1. France Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fertility Drugs Market

• 19.1. Italy Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fertility Drugs Market

• 20.1. Spain Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fertility Drugs Market

• 21.1. Eastern Europe Fertility Drugs Market Overview
• 21.2. Eastern Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fertility Drugs Market

• 22.1. Russia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fertility Drugs Market

• 23.1. North America Fertility Drugs Market Overview
• 23.2. North America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fertility Drugs Market

• 24.1. USA Fertility Drugs Market Overview
• 24.2. USA Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fertility Drugs Market

• 25.1. Canada Fertility Drugs Market Overview
• 25.2. Canada Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fertility Drugs Market

• 26.1. South America Fertility Drugs Market Overview
• 26.2. South America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fertility Drugs Market

• 27.1. Brazil Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fertility Drugs Market

• 28.1. Middle East Fertility Drugs Market Overview
• 28.2. Middle East Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fertility Drugs Market

• 29.1. Africa Fertility Drugs Market Overview
• 29.2. Africa Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fertility Drugs Market Competitive Landscape And Company Profiles

• 30.1. Fertility Drugs Market Competitive Landscape
• 30.2. Fertility Drugs Market Company Profiles
  • 30.2.1. Merck & Co.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Ferring Pharmaceuticals Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Berlex Laboratories Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Janssen Pharmaceutical Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Fertility Drugs Market Competitive Benchmarking

32. Global Fertility Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Fertility Drugs Market

34. Fertility Drugs Market Future Outlook and Potential Analysis

• 34.1 Fertility Drugs Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Fertility Drugs Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Fertility Drugs Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer